Chronic Idiopathic Thrombocytopenic Purpura

Chronic Idiopathic Thrombocytopenic Purpura is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.

Classified under: Allergic Diseases
Anatomical Structures and Fluids
Chemically-Induced Disorders
Hemic and Lymphatic Diseases
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Vascular Diseases
Indicated drugs: Human immunoglobulin G

Resolves to

Vocabularies

SNOMED CT13172003UMLSC0272293

What you can answer from here — as of October 26, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

6Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Chronic Idiopathic Thrombocytopenic Purpura share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.